A Trans-Pacific Biotech Relay Model; Pfizer ADC's Phase 3 Flop and A BioTwitter Debate Over a Newco; A Communication Guidebook for Asian Biotechs

Asian Biotechies In A Bar; Issue 146; 2026-06-28